EUVIMEDEUVIMED entdecken
Crossref

Global burden of heart failure attributable to hypertensive heart disease: a 30-year population-based analysis using Global Burden of Disease 2021 data

Yun Huang iD, Lili Ma, Yuyu Zhang, Weibo Rong, Ronghui Zhang, Chongbo Fang, Rixiang Wang, Hua Zhou

American Journal of Hypertension · 2026

DOI: 10.1093/ajh/hpaf232 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Hypertension, 2026. Verfasst von Yun Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Affiliated LiHuili Hospital of Ningbo University, Ningbo, Zhijiang, China. Hauptthemen laut MEDLINE: Heart Failure, Hypertension. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Zhejiang Provincial Medical and Health Science and Technology Project, Zhejiang Provincial Medical Association Clinical Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hypertensive heart disease is a major cause of heart failure (HF); this study evaluates the global burden and trends of HF attributable to hypertensive heart disease from 1990 to 2021.

Methods

We collected detailed information on prevalence, years lived with disability of HF attributable to hypertensive heart disease from the Global Burden of Disease study 2021 across 204 countries and territories. Numbers, age-standardized rates, and average annual percent change of HF attributable to hypertensive heart disease prevalence and years lived with disability were compared by age, sex, and socio-demographic index.

Results

In 1990 and 2021, hypertensive heart disease-related HF affected more than 4.6 million and 13 million individuals globally, demonstrating an age-standardized prevalence rate of 125.4 [95% uncertainty interval (UI), 99.0 to 158.0] and 148.3 per 100,000 (95% UI, 117.3-186.3) and an age-standardized years lived with disability rate of 11.2 (95% UI, 7.2-15.7) and 13.2 (95% UI, 8.4-19.1) per 100,000, respectively. Notably, from 1990 to 2021, the global age-standardized prevalence and years lived with disability rates increased consistently, with an average annual percent change of 0.53 (95% CI, 0.52-0.54) and 0.54 (95% CI, 0.53-0.55), respectively.

Conclusions

The global burden of HF attributable to hypertensive heart disease has risen.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureHypertensionHumansMaleFemaleGlobal Burden of DiseasePrevalenceMiddle AgedAgedGlobal HealthAdultTime FactorsAged, 80 and over

Stichwörter der Autor:innen

blood pressureepidemiologyheart failurehypertensionhypertensive heart disease

Autor:innen und Institutionen

  • Department of Pharmacy, The Affiliated LiHuili Hospital of Ningbo University, Ningbo, Zhijiang, China.

ORCID-Profile: Yun Huang

Förderung

  • Zhejiang Provincial Medical and Health Science and Technology Project
  • Zhejiang Provincial Medical Association Clinical Research Fund

Zitieren

APA

Huang, Y., Ma, L., Zhang, Y., Rong, W., Zhang, R., Fang, C., Wang, R., & Zhou, H. (2026). Global burden of heart failure attributable to hypertensive heart disease: a 30-year population-based analysis using Global Burden of Disease 2021 data. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpaf232

Vancouver

Huang Y, Ma L, Zhang Y, Rong W, Zhang R, Fang C, et al. Global burden of heart failure attributable to hypertensive heart disease: a 30-year population-based analysis using Global Burden of Disease 2021 data. American Journal of Hypertension. 2026. doi:10.1093/ajh/hpaf232

BibTeX
@article{Huang2026,
  author = {Huang, Yun and Ma, Lili and Zhang, Yuyu and Rong, Weibo and Zhang, Ronghui and Fang, Chongbo and Wang, Rixiang and Zhou, Hua},
  title = {Global burden of heart failure attributable to hypertensive heart disease: a 30-year population-based analysis using Global Burden of Disease 2021 data},
  journal = {American Journal of Hypertension},
  year = {2026},
  doi = {10.1093/ajh/hpaf232}
}
Kostenlos starten →